1. Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). Issue 163 (March 2018) Authors: Padayattil Jose, S.; Banzato, A.; Carraro, P.; Haleh, A.; Rossi, K.; Nante, G.; Denas, G.; Zoppellaro, G.; Pengo, V. Journal: Thrombosis research Issue: Issue 163(2018) Page Start: 100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non‐valvular atrial fibrillation. (19th September 2016) Authors: Bertozzo, G.; Zoppellaro, G.; Granziera, S.; Marigo, L.; Rossi, K.; Petruzzellis, F.; Perissinotto, E.; Manzato, E.; Nante, G.; Pengo, V. Journal: Journal of thrombosis and haemostasis Issue: Volume 14:Number 11(2016:Nov.) Page Start: 2124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study. (13th May 2015) Authors: Riva, N.; Ageno, W.; Poli, D.; Testa, S.; Rupoli, S.; Santoro, R.; Lerede, T.; Piana, A.; Carpenedo, M.; Nicolini, A.; Ferrini, P. M.; Tosetto, A.; the Italian Federation of Anticoagulation Clinics (FCSA); Paoletti, O.; Rancan, E.; Federici, I.; Canafoglia, L.; Maggioni, A.; Falanga, A.; Martini, G. Journal: Journal of thrombosis and haemostasis Issue: Volume 13:Number 6(2015:Jun.) Page Start: 1019 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗